Finoriq research workspace
Aspire Biopharma Holdings, Inc. (ASBP) Company Overview
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets. Review ASBP filings, fundamentals, valuation, and ownership on Finoriq.
Company Snapshot
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
- Company
- Aspire Biopharma Holdings, Inc. (ASBP)
- Ticker
- ASBP
- Market Cap
- $8.5M
- Latest Price
- $6.55
- Industry
- Biotech & Pharma
Aspire Biopharma Holdings, Inc. (ASBP) Current Valuation Metrics
Static valuation preview for Aspire Biopharma Holdings, Inc. (ASBP). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/SMarket cap divided by latest TTM revenue. | 1,260x | Revenue | TTM FY 2025 |
| Earnings YieldLatest TTM net income divided by market cap. | -313.2% | Net Income | TTM FY 2025 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -63.0% | Operating Cash Flow | TTM FY 2025 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.